Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
194M
-
Number of holders
-
214
-
Total 13F shares, excl. options
-
159M
-
Shares change
-
+310K
-
Total reported value, excl. options
-
$9B
-
Value change
-
+$36.8M
-
Put/Call ratio
-
1.13
-
Number of buys
-
114
-
Number of sells
-
-137
-
Price
-
$56.44
Significant Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q2 2014
299 filings reported holding INCY - INCYTE CORP - COMMON STOCK as of Q2 2014.
INCYTE CORP - COMMON STOCK (INCY) has 214 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 159M shares
of 194M outstanding shares and own 82.4% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (21M shares), Capital World Investors (17.7M shares), WELLINGTON MANAGEMENT CO LLP (16.2M shares), BAKER BROS. ADVISORS LP (14.8M shares), VANGUARD GROUP INC (8.41M shares), JENNISON ASSOCIATES LLC (7.12M shares), BB Biotech AG (4.16M shares), Artisan Partners Limited Partnership (4.12M shares), FRANKLIN RESOURCES INC (3.86M shares), and BlackRock Institutional Trust Company, N.A. (3.61M shares).
This table shows the top 214 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.